Reduction of the endogenous expression of c-MYC in human T-ALL cell lines (Jurkat, MOLT-4, P-12, CCRF-CEM) resulted in DNMT3B downregulation. This evidence concerns the gene DNMT3B and acute lymphoblastic leukemia.